Financial Gravity Asset Management, Inc. Ascendis Pharma A/S Transaction History

Financial Gravity Asset Management, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jun 26, 2024	BUY	$86.1 - $127.36 $172 - $254	2 New	2 $212,000
Q3 2023 Nov 15, 2023	SELL	$86.5 - $103.97 $7,525 - $9,045	-87 Reduced 97.75%	2 $0
Q2 2023 Aug 08, 2023	SELL	$69.96 - $97.84 $1,259 - $1,761	-18 Reduced 16.82%	89 $47,000
Q1 2023 May 12, 2023	SELL	$104.9 - $126.78 $1,573 - $1,901	-15 Reduced 12.3%	107 $181,000
Q4 2022 Feb 15, 2023	SELL	$99.42 - $131.97 $18,591 - $24,678	-187 Reduced 60.52%	122 $35,000
Q3 2022 Nov 03, 2022	BUY	$84.03 - $110.23 $2,520 - $3,306	30 Added 10.75%	309 $175,000
Q2 2022 Aug 05, 2022	SELL	$78.08 - $117.61 $5,621 - $8,467	-72 Reduced 20.51%	279 $156,000
Q1 2022 May 13, 2022	SELL	$102.18 - $135.75 $364,169 - $483,813	-3,564 Reduced 91.03%	351 $198,000
Q4 2021 Feb 11, 2022	BUY	$127.1 - $169.66 $494,164 - $659,638	3,888 Added 14400.0%	3,915 $3.64 Million
Q3 2021 Nov 12, 2021	BUY	$112.67 - $176.92 $3,042 - $4,776	27 New	27 $159,000
Q1 2020 May 12, 2020	SELL	$97.01 - $145.11 $31,625 - $47,305	-326 Closed	0 $0
Q4 2019 Feb 28, 2020	SELL	$91.45 - $139.12 $25,514 - $38,814	-279 Reduced 46.12%	326 $139,000
Q3 2019 Oct 15, 2019	SELL	$95.8 - $118.9 $25,003 - $31,032	-261 Reduced 30.14%	605 $58,000
Q2 2019 Jul 26, 2019	SELL	$107.11 - $132.09 $28,598 - $35,268	-267 Reduced 23.57%	866 $100,000
Q1 2019 Apr 19, 2019	BUY	$62.15 - $129.99 $70,291 - $147,018	1,131 Added 56550.0%	1,133 $128,000
Q2 2018 Aug 14, 2018	SELL	$58.55 - $73.92 $58 - $73	-1 Reduced 33.33%	2 $0
Q1 2018 May 23, 2018	BUY	$38.98 - $68.04 $116 - $204	3 New	3 $0

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.